Is the Imported Fritillaria Agency a Scam or a Gold Mine?

"Mr. Zhang represented a batch of European - imported fritillaria last year, and his profit doubled in just three months; Ms. Li introduced Middle - Eastern fritillaria into the domestic high - end market through cross - border cooperation and has now established her own brand..." Have you heard such stories? The imported fritillaria agency, this seemingly niche field, is quietly becoming the "invisible gold mine" in the health industry. Today, let's uncover its mysterious veil.

In recent years, with the acceleration of the internationalization process of traditional Chinese medicine, the market gap for high - quality fritillaria is as high as 40%. Domestic traditional production areas are limited by climate and planting techniques, while fritillaria from Japan, South Korea, Europe, and other places, due to standardized planting and strict quality inspection, have become "hot items" in pharmaceutical companies and the high - end health - preservation market. Supply chain data from Zhongshitong shows that the customs clearance volume of imported fritillaria in 2023 increased by 217% year - on - year.

• Quality advantage: The saponin content of German fritillaria exceeds the national standard by 1.8 times
• Premium space: The terminal selling price of imported products can reach 3 - 5 times that of domestic products
• Policy benefits: The "positive list" of cross - border e - commerce has added the fritillaria category

Ms. Wang once believed the agency of "low - priced Iranian fritillaria" and found that the insect - eaten rate exceeded the standard by 30% after receiving the goods, ultimately suffering a loss of 800,000 yuan. What hidden risks are there in this industry?

The first pitfall: Qualification trap. Imported medicinal materials need to meet three requirements simultaneously: the origin quarantine certificate, the standards of the Chinese Pharmacopoeia, and the import approval documents for medicinal materials. Some agents claim to have "complete double certificates" but actually lack key documents.

The second pitfall: Logistics minefield. Fritillaria is extremely sensitive to temperature and humidity. Due to the out - of - control temperature in a shipping container, 20 tons of goods of a certain agent all became moldy, resulting in a loss of over one million yuan.

The third pitfall: Market misjudgment. Although Japanese fritillaria has excellent quality, domestic consumers prefer the taste of Sichuan fritillaria. Some agents faced unsalable products due to cultural differences.

A industry consultant who has been engaged in the import of medicinal materials agency for more than ten years put forward three suggestions:

• Give priority to choosing planting bases with EU GMP certification or Japanese JAS organic certification
• Logistics must adopt the constant - temperature vacuum packaging + full - process temperature - control traceability system
• When conducting small - batch trial sales, focus on testing the recognition of pharmaceutical company laboratories

With the implementation of the 2025 Outline for the Internationalization of Traditional Chinese Medicine, the imported fritillaria agency will show three trends: customized planting (directional production according to the needs of Chinese pharmaceutical companies), blockchain traceability (the whole process from planting to sales can be traced), and deep - processing value - addition (export of extracts instead of raw materials). A certain industry report predicts that the market size will exceed 500 million yuan by 2028.

"Rather than competing in the red - ocean market, it is better to explore the blue - ocean field." This is the consensus of many successful agents. Have you also discovered the business opportunities of imported fritillaria around you? Welcome to share your observations or confusion in the comment section, and we will select three readers to give away the electronic version of the compliance guide for imported medicinal materials.